By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danish bioinformatics and systems biology firm Intomics said today that H. Lundbeck will use its research services for data analysis and integration in its drug development process.

Under the agreement, Intomics will provide Lundbeck with data analysis and systems biology expertise, methods, and tools for analyzing and integrating the large amounts of biological data it generates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.